In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Therion Biologics and National Cancer Institute initiate clinical studies
Therion Biologics obtains rights to Biogen Idec LFA-3 patents
Aventis Pasteur acquires exclusive rights to cancer targets
Aventis Pasteur acquires rights to cancer targets
Dynavax and Aventis Pasteur announce vaccine collaboration
Epimmune and Aventis enter into license option agreement
Sanofi Pasteur and Institut Pasteur team up against malaria
Provalis signs Vaccine Option Agreement with Aventis Pasteur
Sanofi Pasteur and the Alliance for Rabies Control enter into a Global Partnership